tiprankstipranks
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Income Statement

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Income Statement

Last quarter (Q3 2023), BrightPath Biotherapeutics Co.Ltd.'s total revenue was ¥23.00K, a decrease of -99.54% from the same quarter last year. In Q3, BrightPath Biotherapeutics Co.Ltd.'s net income was ¥-399.84M. See BrightPath Biotherapeutics Co.Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 72.00K¥ 5.28M¥ 15.41M¥ 2.50M¥ 11.30M
Gross Profit
¥ -341.00K¥ 3.38M¥ 12.09M¥ 1.36M¥ 6.83M
Operating Expenses
¥ 1.15B¥ 1.47B¥ 1.49B¥ 1.73B¥ 1.83B
Depreciation and Amortization
¥ 395.00K¥ 16.72M¥ 35.12M¥ 66.69M¥ 62.47M
EBITDA
¥ -1.17B¥ -1.47B¥ -1.45B¥ -1.65B¥ -1.76B
Operating Income
¥ -1.16B¥ -1.47B¥ -1.48B¥ -1.73B¥ -1.83B
Other Income/Expenses
¥ -11.10M¥ -16.67M¥ -5.74M¥ 15.59M¥ -32.51M
Pretax Income
¥ -1.17B¥ -1.48B¥ -1.48B¥ -1.72B¥ -1.86B
Net Income
¥ -1.17B¥ -1.49B¥ -1.48B¥ -1.72B¥ -1.86B
Per Share Metrics
Basic EPS
¥ -18.21¥ -24.90¥ -28.55¥ -36.14¥ -44.20
Diluted EPS
¥ -18.21¥ -24.90¥ -28.55¥ -36.14¥ -44.20
Weighted Average Shares Outstanding
64.16M 59.66M 51.99M 47.58M 42.03M
Weighted Average Shares Outstanding (Diluted)
64.16M 59.66M 51.99M 47.58M 42.03M
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis